JPRN-UMIN000018344已完成未知
Evaluation of Preventive Effect of tofogliflozin on cardiovascular function in type 2 diabetes with cardiovascular diseases - tofogliflozin study
tofogliflozin study group0 个研究点目标入组 30 人开始时间: 2015年9月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) BMI < 18.0 2) history of cerebral infarction 3) patients whose dose of diuretics are changed within 3 months 4) estimated GFR < 45 ml/min 5) patients inplanted pacemaker 6) patients with pregnancy and lactation 7) patiets enrolled other clinical trial
研究者
相似试验
已完成
不适用
Comparison of safety and efficacy of Tofogliflozin and Ipragliflozin in patients with type 2 diabetestype 2 diabetesJPRN-UMIN000037158Minami Osaka hospital24
招募中
4 期
Effect of tofogliflozin on pancreatic beta-cell functioType 2 diabetesJPRN-jRCTs011230006akamura Akinobu70
已完成
不适用
Effects of tofogliflozin treatment on suppression of nocturia and promotion of urinary sodium excretion.JPRN-UMIN000048030Department of Metabolism and Endocrinology, Akita University Graduate School of Medicine36
未知
2 期
Clinical Pharmacology Study of Tofogliflozin --Evaluation of influence by degree of kidney functionType 2 diabetesJPRN-jRCT2080221532Chugai Pharmaceutical Co., Ltd.40
未知
1 期
Drug-drug interaction study (2) of TofoglifloziJPRN-jRCT2080221710Chugai Pharmaceutical Co., Ltd.87